We are live on ! Find out more
GIA

Gateway Investment Advisers Portfolio holdings

AUM $10.1B
1-Year Est. Return 40.26%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+40.26%
3 Year Est. Return
+126.95%
5 Year Est. Return
+174.82%
10 Year Est. Return
+615.41%
AUM
$10.1B
AUM Growth
+$211M
Cap. Flow
-$632M
Cap. Flow %
-6.24%
Top 10 Hldgs %
25.39%
Holding
574
New
7
Increased
97
Reduced
438
Closed
17

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$15.9M
2
HAL icon
Halliburton
HAL
+$15.3M
3
LVS icon
Las Vegas Sands
LVS
+$8.57M
4
SUI icon
Sun Communities
SUI
+$7.24M
5
CDW icon
CDW
CDW
+$5.98M

Sector Composition

Rank Sector Weight
1 Technology 21.11%
2 Financials 14.99%
3 Healthcare 13.96%
4 Communication Services 10.6%
5 Consumer Discretionary 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
426
Stryker
SYK
$130B
$609K 0.01%
2,899
-301
-9% -$62.5K
CVE icon
427
Cenovus Energy
CVE
$52.1B
$599K 0.01%
59,059
SU icon
428
Suncor Energy
SU
$70.3B
$597K 0.01%
18,190
+401
+2% +$12.5K
CHD icon
429
Church & Dwight Co
CHD
$24.5B
$596K 0.01%
8,480
-549
-6% -$39K
ROP icon
430
Roper Technologies
ROP
$39.8B
$592K 0.01%
1,670
-470
-22% -$162K
ZTS icon
431
Zoetis
ZTS
$30B
$590K 0.01%
4,457
-498
-10% -$61.9K
AWK icon
432
American Water Works
AWK
$26.9B
$584K 0.01%
4,751
-124
-3% -$15K
PPG icon
433
PPG Industries
PPG
$26.6B
$561K 0.01%
4,203
-393
-9% -$49.8K
MXIM
434
DELISTED
Maxim Integrated Products
MXIM
$552K 0.01%
8,979
-540
-6% -$31.4K
M icon
435
Macy's
M
$6.68B
$548K 0.01%
32,221
-353
-1% -$5.52K
INTU icon
436
Intuit
INTU
$89B
$546K 0.01%
2,085
-237
-10% -$62K
AME icon
437
Ametek
AME
$58.2B
$543K 0.01%
5,443
-628
-10% -$59.5K
SPG icon
438
Simon Property Group
SPG
$72.3B
$526K 0.01%
3,529
-670
-16% -$100K
NWL icon
439
Newell Brands
NWL
$2.56B
$521K 0.01%
27,132
-1,134
-4% -$21.8K
TROW icon
440
T. Rowe Price
TROW
$24.3B
$521K 0.01%
4,278
-516
-11% -$60.9K
O icon
441
Realty Income
O
$59.1B
$497K ﹤0.01%
6,965
-241
-3% -$17.9K
ALNY icon
442
Alnylam Pharmaceuticals
ALNY
$29.3B
$486K ﹤0.01%
4,220
-97
-2% -$9.67K
MET icon
443
MetLife
MET
$62.1B
$485K ﹤0.01%
9,524
-2,781
-23% -$134K
APH icon
444
Amphenol
APH
$209B
$482K ﹤0.01%
17,824
-1,380
-7% -$35.2K
PXD
445
DELISTED
Pioneer Natural Resource Co.
PXD
$474K ﹤0.01%
3,129
-302
-9% -$40.2K
ASIX icon
446
AdvanSix
ASIX
$444M
$472K ﹤0.01%
23,623
-41,676
-64% -$911K
IDXX icon
447
Idexx Laboratories
IDXX
$46.2B
$470K ﹤0.01%
1,801
-163
-8% -$43K
MCO icon
448
Moody's
MCO
$82.7B
$470K ﹤0.01%
1,981
-252
-11% -$56K
TEL icon
449
TE Connectivity
TEL
$62.6B
$461K ﹤0.01%
4,811
-471
-9% -$43.6K
OVV icon
450
Ovintiv
OVV
$16.4B
$458K ﹤0.01%
19,541
-1,363
-7% -$29.2K

Similar funds

Gateway Investment Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Gateway Investment Advisers held 574 positions worth $10.1B, up 2.1% from $9.92B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gateway Investment Advisers withdrew a net $632M in Q4 2019, closing 17 positions and reducing 438 holdings. Its most notable exit was Celgene Corp, an estimated $37.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Gateway Investment Advisers opened a new position in UGI worth $641K.

  • Gateway Investment Advisers's largest Q4 2019 buy was UGI: 14,205 shares worth $641K.
  • Gateway Investment Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $15.9M increase.
  • Gateway Investment Advisers's biggest Q4 2019 reduction was US Bancorp, cutting an estimated $48.8M.
  • Gateway Investment Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $37.7M.
  • Gateway Investment Advisers's ten largest holdings make up 25% of its $10.1B portfolio in Q4 2019.
  • Gateway Investment Advisers opened 7 new positions and closed 17 in Q4 2019.
  • Gateway Investment Advisers's portfolio value rose 2.1% quarter-over-quarter to $10.1B.

Based on Gateway Investment Advisers's 13F filing for Q4 2019, filed 9 Jan 2020.